Join Agatha Head of North American Operations, Ken Lownie, and Janine Penman, JPScientific, as they take you through the strategy of bringing your TMF in-house.
In part one of the series, Ken and Janine discuss the following:
Who typically "owns" the TMF?Is there a pattern between larger and smaller sponsors as to when the TMF is usually outsourced?What is the "best practice" for smaller, clinical-stage sponsors regarding TMF managementWhat is driving the need to bring the TMF in-house and how do you know WHEN it makes sense for a specific organization to think about taking the TMF in-house? The challenges involved when moving from your CRO managing the TMF to bringing it in-house.Sign up for Agatha's newsletter to get updated when each new episode in the series goes live and to get additional insights on each episode.